{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:37:59Z","timestamp":1781937479388,"version":"3.54.5"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:p>OBJECTIVE. Antenatal dexamethasone and betamethasone may not be equally efficacious in the prevention of adverse neonatal outcomes. We compared the risks of periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and neonatal death among very low birth weight infants who were exposed to dexamethasone, betamethasone, or neither steroid.<\/jats:p><jats:p>METHODS. Infants (401\u20131500 g) in the National Institute of Child Health and Human Development Neonatal Research Network were studied. Multivariate logistic regression analyses compared the 3 groups with regard to PVL, IVH, ROP, and neonatal death, adjusting for network center and selected covariates.<\/jats:p><jats:p>RESULTS. A total of 3600 infants met entry criteria. Compared with no antenatal steroids, there were trends for a reduced risk for PVL associated with dexamethasone and betamethasone but no difference in risk between dexamethasone and betamethasone. Dexamethasone reduced the risk for IVH and severe IVH, compared with no antenatal steroid exposure. Betamethasone reduced the risk for IVH, severe IVH, and neonatal death, compared with no antenatal steroids. Compared with betamethasone, dexamethasone had a statistically significant increased risk for neonatal death. There were trends for greater risks associated with dexamethasone compared with betamethasone for IVH and severe ROP.<\/jats:p><jats:p>CONCLUSIONS. Betamethasone was associated with a reduced risk for neonatal death, with trends of decreased risk for other adverse neonatal outcomes, compared with dexamethasone. It may be in the best interest of neonates to receive betamethasone rather than dexamethasone when available.<\/jats:p>","DOI":"10.1542\/peds.2005-1749","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T17:22:05Z","timestamp":1146504125000},"page":"1503-1510","source":"Crossref","is-referenced-by-count":108,"title":["Adverse Neonatal Outcomes Associated With Antenatal Dexamethasone Versus Antenatal Betamethasone"],"prefix":"10.1542","volume":"117","author":[{"given":"Ben H.","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Stoll","sequence":"additional","affiliation":[{"name":"Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Research Triangle Institute, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary D.","family":"Higgins","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the National Institute of Child Health and Human Development Neonatal Research Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"2021120823231284400_R1","doi-asserted-by":"crossref","unstructured":"Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics.\u20081972;50:515\u2013525","DOI":"10.1542\/peds.50.4.515"},{"key":"2021120823231284400_R2","doi-asserted-by":"crossref","unstructured":"Shankaran S, Bauer CR, Bain R, Wright LL, Zachary J. Relationship between antenatal steroid administration and grades III and IV intracranial hemorrhage in low birth weight infants. The NICHD Neonatal Research Network. Am J Obstet Gynecol.\u20081995;173:305\u2013312","DOI":"10.1016\/0002-9378(95)90219-8"},{"key":"2021120823231284400_R3","doi-asserted-by":"crossref","unstructured":"Wright LL, Verter J, Younes N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol.\u20081995;173:269\u2013274","DOI":"10.1016\/0002-9378(95)90212-0"},{"key":"2021120823231284400_R4","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA.\u20081995;273:413\u2013418","DOI":"10.1001\/jama.273.5.413"},{"key":"2021120823231284400_R5","doi-asserted-by":"crossref","unstructured":"Wells LR, Papile LA, Gardner MO, Hartenberger CR, Merker L. Impact of antenatal corticosteroid therapy in very low birth weight infants on chronic lung disease and other morbidities of prematurity. J Perinatol.\u20081999;19:578\u2013581","DOI":"10.1038\/sj.jp.7200268"},{"key":"2021120823231284400_R6","doi-asserted-by":"crossref","unstructured":"Leviton A, Dammann O, Allred EN, et al. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol.\u20081999;181:1007\u20131017","DOI":"10.1016\/S0002-9378(99)70344-3"},{"key":"2021120823231284400_R7","unstructured":"Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev.\u20082000;2:CD000065"},{"key":"2021120823231284400_R8","doi-asserted-by":"crossref","unstructured":"Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med.\u20081999;341:1190\u20131196","DOI":"10.1056\/NEJM199910143411604"},{"key":"2021120823231284400_R9","doi-asserted-by":"crossref","unstructured":"Rayburn WF, Christensen HD, Gonzalez CL. A placebo-controlled comparison between betamethasone and dexamethasone for fetal maturation: differences in neurobehavioral development of mice offspring. Am J Obstet Gynecol.\u20081997;176:842\u2013850","DOI":"10.1016\/S0002-9378(97)70609-4"},{"key":"2021120823231284400_R10","doi-asserted-by":"crossref","unstructured":"The Italian ROP Study Group. Italian multicentre study on retinopathy of prematurity. Eur J Pediatr.\u20081997;156:939\u2013943","DOI":"10.1007\/s004310050747"},{"key":"2021120823231284400_R11","doi-asserted-by":"crossref","unstructured":"Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol.\u20081998;116:601\u2013605","DOI":"10.1001\/archopht.116.5.601"},{"key":"2021120823231284400_R12","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol.\u20081981;141:276\u2013287","DOI":"10.1016\/S0002-9378(16)32633-3"},{"key":"2021120823231284400_R13","doi-asserted-by":"crossref","unstructured":"Hack M, Horbar JD, Malloy MH, Tyson JE, Wright E, Wright L. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics.\u20081991;87:587\u2013597","DOI":"10.1542\/peds.87.5.587"},{"key":"2021120823231284400_R14","doi-asserted-by":"crossref","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr.\u20081978;92:529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120823231284400_R15","doi-asserted-by":"crossref","unstructured":"Zupan V, Gonzalez P, Lacaze-Masmonteil T, et al. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol.\u20081996;38:1061\u20131067","DOI":"10.1111\/j.1469-8749.1996.tb15068.x"},{"key":"2021120823231284400_R16","doi-asserted-by":"crossref","unstructured":"Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet.\u20081995;346:1449\u20131454","DOI":"10.1016\/S0140-6736(95)92471-X"},{"key":"2021120823231284400_R17","doi-asserted-by":"crossref","unstructured":"Deulofeut R, Sola A, Lee B, Buchter S, Rahman M, Rogido M. The impact of vaginal delivery in premature infants weighing less than 1,251 grams. Obstet Gynecol.\u20082005;105:525\u2013531","DOI":"10.1097\/01.AOG.0000154156.51578.50"},{"key":"2021120823231284400_R18","doi-asserted-by":"crossref","unstructured":"Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development Neonatal Research Network, January 1995 through December 1996. Pediatrics.\u20082001;107:1\u20138","DOI":"10.1542\/peds.107.1.e1"},{"key":"2021120823231284400_R19","doi-asserted-by":"crossref","unstructured":"Rotschild T, Nandgaonkar BN, Yu K, Higgins RD. Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res.\u20081999;46:94\u2013100","DOI":"10.1203\/00006450-199907000-00016"},{"key":"2021120823231284400_R20","unstructured":"Yossuck P, Yan Y, Tadesse M, Higgins RD. Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci.\u20082000;41:3095\u20133099"},{"key":"2021120823231284400_R21","doi-asserted-by":"crossref","unstructured":"Yossuck P, Yan Y, Tadesse M, Higgins RD. Dexamethasone alters TNF-alpha expression in retinopathy. Mol Genet Metab.\u20082001;72:164\u2013167","DOI":"10.1006\/mgme.2000.3124"},{"key":"2021120823231284400_R22","doi-asserted-by":"crossref","unstructured":"Jobe AH, Soll RF. Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol.\u20082004;190:878\u2013881","DOI":"10.1016\/j.ajog.2004.01.044"},{"key":"2021120823231284400_R23","doi-asserted-by":"crossref","unstructured":"Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol.\u20081999;58:363\u2013368","DOI":"10.1016\/S0006-2952(99)00090-8"},{"key":"2021120823231284400_R24","doi-asserted-by":"crossref","unstructured":"McGowan JE, Sysyn G, Petersson KH, et al. Effect of dexamethasone treatment on maturational changes in the NMDA receptor in sheep brain. J Neurosci.\u20082000;20:7424\u20137429","DOI":"10.1523\/JNEUROSCI.20-19-07424.2000"},{"key":"2021120823231284400_R25","doi-asserted-by":"crossref","unstructured":"Helve O, Pitkanen OM, Andersson S, O'Brodovich H, Kirjavainen T, Otulakowski G. Low expression of human epithelial sodium channel in airway epithelium of preterm infants with respiratory distress. Pediatrics.\u20082004;113:1267\u20131272","DOI":"10.1542\/peds.113.5.1267"},{"key":"2021120823231284400_R26","doi-asserted-by":"crossref","unstructured":"Wang ZM, Yasui M, Celsi G. Differential effects of glucocorticoids and mineralocorticoids on the mRNA expression of colon ion transporters in infant rats. Pediatr Res.\u20081995;38:164\u2013168","DOI":"10.1203\/00006450-199508000-00005"},{"key":"2021120823231284400_R27","doi-asserted-by":"crossref","unstructured":"Reist M, Marshall KA, Jenner P, Halliwell B. Toxic effects of sulfite in combination with peroxynitrite on neuronal cells. J Neurochem.\u20081998;71:2431\u20132438","DOI":"10.1046\/j.1471-4159.1998.71062431.x"},{"key":"2021120823231284400_R28","doi-asserted-by":"crossref","unstructured":"Baud O, Laudenbach V, Evrard P, Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res.\u20082001;50:706\u2013711","DOI":"10.1203\/00006450-200112000-00013"},{"key":"2021120823231284400_R29","doi-asserted-by":"crossref","unstructured":"Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. Br J Obstet Gynecol.\u20082003;110:124\u2013127","DOI":"10.1046\/j.1471-0528.2003.00063.x"},{"key":"2021120823231284400_R30","doi-asserted-by":"crossref","unstructured":"Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology.\u20082002;22:106\u2013132","DOI":"10.1046\/j.1440-1789.2002.00438.x"},{"key":"2021120823231284400_R31","doi-asserted-by":"crossref","unstructured":"O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics.\u20081999;104:15\u201321","DOI":"10.1542\/peds.104.1.15"},{"key":"2021120823231284400_R32","doi-asserted-by":"crossref","unstructured":"Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed.\u20082000;83:177\u2013181","DOI":"10.1136\/fn.83.3.F177"},{"key":"2021120823231284400_R33","doi-asserted-by":"crossref","unstructured":"Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med.\u20082004;350:1304\u20131313","DOI":"10.1056\/NEJMoa032089"},{"key":"2021120823231284400_R34","doi-asserted-by":"crossref","unstructured":"Paneth N. Classifying brain damage in preterm infants. J Pediatr.\u20081999;134:527\u2013529","DOI":"10.1016\/S0022-3476(99)70231-3"},{"key":"2021120823231284400_R35","doi-asserted-by":"crossref","unstructured":"Inder T, Huppi PS, Zientara GP, et al. Early detection of periventricular leukomalacia by diffusion-weighted magnetic resonance imaging techniques. J Pediatr.\u20081999;134:631\u2013634","DOI":"10.1016\/S0022-3476(99)70251-9"},{"key":"2021120823231284400_R36","doi-asserted-by":"crossref","unstructured":"Golomb MR, Dick PT, MacGregor DL, Armstrong DC, DeVeber GA. Cranial ultrasonography has a low sensitivity for detecting arterial ischemic stroke in term neonates. J Child Neurol.\u20082003;18:98\u2013103","DOI":"10.1177\/08830738030180021401"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/5\/1503\/1070673\/zpe00506001503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/5\/1503\/1070673\/zpe00506001503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T08:36:40Z","timestamp":1683448600000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/5\/1503\/69978\/Adverse-Neonatal-Outcomes-Associated-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,5,1]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1749","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}